Tarsus Pharmaceuticals to present at three investor conferences in May 2026

Tarsus Pharmaceuticals announced its management will participate in three upcoming investor conferences in May 2026: Bank of America Securities Health Care Conference on May 12, H.C. Wainwright BioConnect Investor Conference on May 19, and Stifel Virtual Ophthalmology Forum on May 26. These events will include live webcasts accessible on the Tarsus website, with replays available for a limited time. The company is advancing treatments in eye care and infectious disease prevention, including its FDA-approved XDEMVY for Demodex blepharitis and pipeline candidates in Phase 2 trials. This participation highlights Tarsus's efforts to engage investors and update them on its progress and financial outlook.